• Home
    • Concept
  • Program
    • Speakers
  • Abstracts
  • Livestream
  • On-demand
  • Partners
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration
info@medupdate-europe.eu
Login

Login
Pneumo Update Europe 2023Pneumo Update Europe 2023
Pneumo Update Europe 2023
23 - 24 June - Amsterdam & Virtual
  • Home
    • Concept
  • Program
    • Speakers
  • Abstracts
  • Livestream
  • On-demand
  • Partners
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration

Scientific Board

buhl

Roland Buhl

Institution:
University Hospital Mainz, Germany

Read More
Roland Buhl is Professor of Medicine and Head of the Pulmonary Department at Mainz University Hospital. He qualified and received his doctorate from the University of Heidelberg and later trained in pulmonary medicine and allergology, first in Berlin and Frankfurt, and then at National Institutes of Health, USA, before receiving his Ph.D. from the University of Frankfurt.

Topic

Asthma
halpin

David M. G. Halpin

Institution:
Royal Devon & Exeter Hospital, Exeter, UK

Read More
David Halpin is currently Consultant Physician & Honorary Associate Professor in Respiratory Medicine at the Royal Devon & Exeter Hospital. He is married with 2 daughters.

He trained at Oxford & St Thomas Hospital Medical School: completing a D.Phil. in the Department of Human Anatomy, Oxford, before finishing his clinical training at St Thomas. He completed his postgraduate training in respiratory medicine at the Brompton Hospital.
He is a Fellow of Royal College Physicians, Member British Thoracic Society, European Respiratory Society & American Thoracic Society.
He leads a busy clinical department, continues research in respiratory medicine & has published widely. He lectures frequently around the world on COPD. He is an Associate Editor of Thorax.
He was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.
Since 2010 he has also been Respiratory Clinical Lead for the NHS in the South West.

Topic

COPD
mcnicholas

Walter McNicholas

Institution:
University College Dublin, St. Vincent’s Hospital Group, Dublin, Ireland

Read More

WALTER MCNICHOLAS is Newman Clinical Research Professor at University College Dublin (UCD) and Consultant in Respiratory and Sleep Medicine at St. Vincent’s Hospital Group, Dublin. He is current President of the European Sleep Research Society (ESRS) and a former President of the European Respiratory Society (ERS). He is a medical graduate of UCD and undertook his postgraduate training in Respiratory and Sleep Medicine at the University of Toronto. Walter is a Research Fellow at the UCD Conway Research Institute and is part of a multidisciplinary research group based in St. Vincent’s and the Conway Institute, which collaborates with other groups within UCD and throughout Europe. His research interests range from human clinical to basic cell and molecular biology, and include the pathophysiology, treatment and outcomes of obstructive sleep apnoea syndrome (OSA), the cardiovascular and metabolic consequences of the disorder, basic cell and molecular mechanisms and consequences of intermittent hypoxia, in addition to sleep disturbances in COPD and other chronic respiratory disorders. He is also closely involved in the evaluation of novel ambulatory monitoring devices for sleep disorders and is active in public health policy around driving risk in patients with OSA and sleepiness. He has supervised many PhD and other Doctoral research students over the past 30 years in his research laboratory at UCD and St. Vincent’s.

Walter is a past Associate Editor of the European Respiratory Journal and has published over 230 full papers in International Peer-reviewed Journals (h-index: 49 in Web of Science; 65 in Google Scholar). He serves on the Editorial Boards of several International Respiratory and Sleep Journals and is Associate or Section Editor in four journals. Walter has held many Leadership positions in National and International organisations. In addition to his current role as President of the European Sleep Research Society, he was President of the European Respiratory Society in 2003-2004 and President of the European Board of Accreditation in Pneumology from 2010-2014. He chaired an EU-sponsored COST Action (B26) on Obstructive Sleep Apnoea (2005-2010), and recently chaired a Working Group established by the Transport and Mobility Directorate of the European Commission on Sleep Apnoea and Driving (2012-2013), which led to an official EU Directive on this topic, issued in June 2014, that is now mandatory throughout all EU member states.

Topic

Sleep Disordered Breathing
Richeldi Luca (2)

Luca Richeldi

Institution:
University Hospital A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy

Read More
Luca Richeldi is Professor of Respiratory Medicine and Director of the Pneumology Unit at the University Hospital A. Gemelli in Rome. He was Chair of Interstitial Lung Disease at the University of Southampton, UK until December 31, 2016. He has also been Associate Professor of Respiratory Medicine in the Department of Oncology, Hematology and Respiratory Diseases at the University of Modena and Reggio Emilia, Italy.

Dr. Richeldi was also the Founder and Director of the Center for Rare Lung Diseases at the same university. From November 2005 to November 2008 he was the Director of the School of Specialization in Respiratory Medicine of the University of Modena and Reggio Emilia. From November 2012 he was the Deputy Dean for Education of the Faculty of Medicine of the University of Modena and Reggio Emilia.  He serves as associate editor for the European Respiratory Journal and is a member of the editorial board of the American Journal of Respiratory and Critical Care Medicine. He is a member of the Microbiology, Tuberculosis and Pulmonary Infections program committee of the American Thoracic Society (ATS). He has been part of the panels in charge of the production of the ATS-ERS guidelines on “Diagnosis of tuberculosis infection” and “Idiopathic pulmonary fibrosis” and is a member and reviewer of the Cochrane Collaboration. Dr. Richeldi is a member of the Fleischner Society and has published more than 100 peer-reviewed papers and contributed several chapters in scientific books.

Topic

Interstitial Lung Diseases
In cooperation with

Accreditation – EACCME & EBAP

The Pneumo Update Europe 2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9 European CME credits (ECMEC®s).

The PUE23  has been found worthy of accreditation by the European Board for Accreditation in Pneumology (EBAP) for 9.5 CME credits covering the whole program.

EBAP reviewers have awarded the Mark of Excellence (MOE) for this activity which is worth an extra 4 CME credits. An MOE is given to activities with exceptionally high quality and standards.

Accreditation – EFPIA & Ethical Medtech

The Pneumo Update Europe 2023 has been assessed COMPLIANT by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the MedTech Europe Code of Ethical Business Practice.

 

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

ethical medtech

www.ethicalmedtech.eu

© 2023

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}